| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.4 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.068 | 0.4 |